Supernus Pharmaceuticals sell melinda
Start price
27.01.14
/
50%
€6.88
Target price
28.07.14
€5.00
Performance (%)
-1.37%
End price
28.07.14
€6.79
Summary
This prediction ended on 28.07.14 with a price of €6.79. With a performance of -1.37%, the SELL prediction for Supernus Pharmaceuticals by melinda was down slightly. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Supernus Pharmaceuticals | 5.109% | 5.109% | 13.386% | 23.077% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
According to melinda what are the pros and cons of Supernus Pharmaceuticals for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Supernus Pharmaceuticals diskutieren
verkaufen
Ziel erreicht
(Laufzeit überschritten)
Stopped prediction by melinda for Supernus Pharmaceuticals
Supernus Pharmaceuticals
Start price
Target price
Perf. (%)
€25.20
25.01.21
25.01.21
€28.00
25.01.22
25.01.22
3.97%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Supernus Pharmaceuticals
Start price
Target price
Perf. (%)
€43.88
09.08.18
09.08.18
€53.94
09.08.19
09.08.19
-41.09%
09.08.19
09.08.19
Could be worthwhile Investment >10% per year